» Articles » PMID: 30973448

Impact of Obstructive Sleep Apnea on Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease

Overview
Specialty General Medicine
Date 2019 Apr 12
PMID 30973448
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) syndrome are highly prevalent respiratory conditions. Their coexistence is referred to as the overlap syndrome. They are both related to pulmonary hypertension (PH) development. This study investigated the effects of OSA on PH in patients with COPD and the associated factors.

Methods: Consecutive patients with stable COPD were recruited for an observational cross-sectional study from September 2016 to May 2018 at Peking University Third Hospital. In total, 106 patients with COPD were enrolled and performed home portable monitoring and echocardiography. OSA was defined by an apnea hypopnea index (AHI) ≥10 events/h. Based on OSA absence or presence, patients were divided into the COPD with OSA and COPD without OSA groups. Factors affecting pulmonary artery pressure (PAP) and PH were identified using univariate analysis and logistic regression models.

Results: In the 106 patients with COPD, the mean age was 69.52 years, 91.5% were men, and the mean forced expiratory volume in 1 s (FEV1) percentage of predicted was 56.15%. Fifty-six (52.8%) patients with COPD were diagnosed with OSA, and 24 (22.6%) patients with COPD were diagnosed as PH. Compared with COPD without OSA group, the median PAP in COPD with severe OSA group increased by 5 mmHg (36.00 [26.00-50.00] mmHg vs. 31.00 [24.00-34.00] mmHg, P = 0.036). COPD with percent of night-time spent with oxygen saturation below 90% (T90) > 10% group had higher PAP than COPD with T90 ≤ 1% group (36.00 [29.00-50.00)] mmHg vs. 29.00 [25.50-34.00] mmHg, F = 7.889, P = 0.007). Univariate analysis revealed age, FEV1% predicted, T90, and Charlson index had statistically significant effects on PH. Multiple regression analysis showed a significant and independent effect of both FEV1% predicted (odds ratio [OR] = 3.46; 95% confidence interval [CI]: 1.15-10.46; P = 0.028) and AHI (OR = 3.20; 95% CI: 1.09-19.35; P = 0.034) on PH.

Conclusions: Patients with COPD with OSA are more susceptible to PH, which is associated with declining lung function and increased severity of OSA. Thus, nocturnal hypoxemia and OSA in elderly patients with COPD should be identified and treated.

Citing Articles

Prevalence of pulmonary hypertension and its associated factors among chronic obstructive pulmonary diseases patients at public hospitals of Addis Ababa, Ethiopia, 2024: a facility-based cross-sectional study.

Kasse T, Elias A, Lonsako A, Agegnehu Y Front Public Health. 2024; 12:1456235.

PMID: 39659724 PMC: 11628547. DOI: 10.3389/fpubh.2024.1456235.


Prevalence and Characteristics of Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease: Overlap Syndrome.

Fanaridis M, Bouloukaki I, Stathakis G, Steiropoulos P, Tzanakis N, Moniaki V Life (Basel). 2024; 14(5).

PMID: 38792569 PMC: 11122385. DOI: 10.3390/life14050547.


Screening and early warning system for chronic obstructive pulmonary disease with obstructive sleep apnoea based on the medical Internet of Things in three levels of healthcare: protocol for a prospective, multicentre, observational cohort study.

Pan Z, Liao S, Sun W, Zhou H, Lin S, Chen D BMJ Open. 2024; 14(2):e075257.

PMID: 38418236 PMC: 10910414. DOI: 10.1136/bmjopen-2023-075257.


The role of neutrophil to lymphocyte ratio in patients with COPD-OSA overlap syndrome.

Yang X, Han X, Liang M, Wang Y, Zhang J, Cao J Sleep Breath. 2024; 28(3):1329-1335.

PMID: 38413554 DOI: 10.1007/s11325-024-03013-4.


The Overlap Syndrome of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease: A Systematic Review.

Czerwaty K, Dzaman K, Sobczyk K, Sikorska K Biomedicines. 2023; 11(1).

PMID: 36672523 PMC: 9856172. DOI: 10.3390/biomedicines11010016.


References
1.
Sajkov D, Wang T, Saunders N, Bune A, Neill A, McEvoy R . Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med. 1999; 159(5 Pt 1):1518-26. DOI: 10.1164/ajrccm.159.5.9805086. View

2.
NIIJIMA M, Kimura H, Edo H, Shinozaki T, Kang J, Masuyama S . Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1999; 159(6):1766-72. DOI: 10.1164/ajrccm.159.6.9808064. View

3.
Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54(7):581-6. PMC: 1745516. DOI: 10.1136/thx.54.7.581. View

4.
Bady E, Achkar A, Pascal S, Orvoen-Frija E, Laaban J . Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax. 2000; 55(11):934-9. PMC: 1745626. DOI: 10.1136/thorax.55.11.934. View

5.
Ip M, Lam B, Lauder I, Tsang K, Chung K, Mok Y . A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest. 2001; 119(1):62-9. DOI: 10.1378/chest.119.1.62. View